Baxter International (BAX) Common Equity (2009 - 2026)

Baxter International (BAX) has 18 years of Common Equity data on file, last reported at $6.0 billion in Q1 2026.

• On a quarterly basis, Common Equity fell 14.33% year-over-year to $6.0 billion in Q1 2026; TTM through Mar 2026 was $6.0 billion, a 14.33% decrease from a year earlier, with the FY2025 full-year figure at $6.1 billion, down 13.13% from the prior year.
• Common Equity for Q1 2026 stood at $6.0 billion, down from $6.1 billion in the prior quarter.
• Over the last five years, Common Equity for BAX reached as high as $9.1 billion in Q1 2022 and fell as low as $5.6 billion in Q3 2022.
• Historically, Common Equity has averaged $7.2 billion across 5 years, with a median of $7.2 billion in 2025.
• On a YoY basis, Common Equity climbed as much as 46.37% in 2023 and fell as far as 36.75% in 2023.
• Year by year, Common Equity stood at $5.9 billion in 2022, then jumped by 43.65% to $8.5 billion in 2023, then fell by 17.05% to $7.0 billion in 2024, then fell by 13.13% to $6.1 billion in 2025, then fell by 0.97% to $6.0 billion in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $6.0 billion in Q1 2026, $6.1 billion in Q4 2025, and $7.2 billion in Q3 2025.